Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01254149 · ClinicalTrials.gov registry record
IOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 43
- Enrollment target
NCT01254149: Completed study, sponsored by University of Nebraska.
NCT01254149 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01254149 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine whether topical ophthalmic anesthetics lower the intraocular pressure in the eye.
Primary Outcome
Intraocular pressure is measured via Goldmann applanation tonometry, which is considered the standard method of measurement with and without anesthetics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2011-01-17 |
| Est. Completion | 2012-04-01 |
What the finished NCT01254149 record still lists
NCT01254149 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01254149 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01254149 about?
NCT01254149 is a clinical study titled "IOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic". The primary purpose of this study is to determine whether topical ophthalmic anesthetics lower the intraocular pressure in the eye.
What is the current status of trial NCT01254149?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2011-01-17. Estimated completion is 2012-04-01.
Who is sponsoring clinical trial NCT01254149?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI